You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
Phase I, open label, healthy volunteers, ADME study with single oral administration of [14C] AZD5069
- Disease
- chronic obstructive pulmonary disease
- Drug Name
- AZD5069
- Generic Name
- AZD5069
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D3550C00013
- Study Id
- D3550C00013
- ClinicalTrials.gov ID
- NCT01332903
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
